AFJKR — AIMEI HEALTH TECHNOLOGY CO L
As of Q2 2026, 1 SEC-registered investment managers reported holding AFJKR (AIMEI HEALTH TECHNOLOGY CO L) in their latest 13F filings, with a combined reported value of $46.50K across 155.00K shares. That is -85.0% by share count (-875.49K shares) versus the previous quarter, while reported value moved -85.7%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
AFJKR is classified in the Financials sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| JPMorgan Chase & Co history | Q1 2026 | 873.04K | $275.01K | 0.02% | New |
| D. E. Shaw & Co history | Q2 2026 | 155.00K | $46.50K | 0.00% | Hold |
| UBS Group AG history | Q1 2026 | 2.45K | $754 | 0.00% | Reduce |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- JPMorgan Chase & Co sold 873.04K sh · $275.01K
- UBS Group AG sold 2.45K sh · $754
Fund Position History — shares by quarter (top 3 funds)
| Fund | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| D. E. Shaw & Co | 155.00K | 155.00K | 155.00K | 155.00K | 155.00K | 155.00K | 155.00K | 155.00K | 155.00K | 155.00K |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | 873.04K | — |
| UBS Group AG | — | — | — | — | 53.96K | 53.96K | 46.68K | 3.46K | 2.45K | — |